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Abstract
Introduction: Neuropsychological assessment of patients with dementia neces-
sitates the use of varied memory tasks designed to measure different memory
processes, including information memorization, retention and retrieval. A valid
memory battery should be demonstrated to discriminate between demented and
non-demented subjects and its scores should be related to the degree of intel-
lectual impairment. The objective of this study was to evaluate the potential use-
fulness of Choynowski’s Memory Scale in assessment of patients with dementia.
Material and methods: Thirty-two patients with dementia and 64 age- and gen-
der- matched healthy controls took part in the study. All participants were exam-
ined by means of Choynowski’s Memory Scale, and the patients were addition-
ally assessed by the Mini Mental State Examination and Clock Drawing Test (CDT). 
Results: All subtests of Choynowski’s Memory Scale were found to highly sig-
nificantly (p ≤ 0.001) discriminate between patients with dementia and healthy
controls. Except for Digit Span, all other subtests of Choynowski’s battery were
highly correlated with the global mental status as assessed by MMSE with cor-
relation coefficients ranging from 0.59 to 0.81. Most subtests of Choynowski’s
Memory Scale were also moderately or highly correlated with performance on
the CDT, and the correlations coefficients between the total score on Memory
Scale and the CDT were r = 0.66 and r = 0.61 (p ≤ 0.001) for the free recall draw-
ing and copying, respectively. 
Conclusions: Choynowski’s Memory Scale showed high discriminative proper-
ties and strong associations with the degree of intellectual impairment in
dementia. The results encourage the use of this battery in clinical settings.
Key words: memory assessment, clock drawing test, dementia diagnosis, Alzheimer
disease, vascular dementia.
Introduction
Dementia is a complex psychopathological syndrome characterized by
impairments in cognition and behaviour with resulting subsequent decline
in activities of daily living [1]. Neuropsychological assessment constitutes
a crucial part of the diagnosis of dementia and involves measurement of
various cognitive, emotional and psychosocial functions carried out by
means of standardized tests. Memory functions are among the most impor-
tant to be measured as the first complaints which motivate the patients
or their family members to seek professional advice typically concern mem-
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ory impairment. Memory functions have been
demonstrated to show subtle impairments as long
as 9 years before the clinical diagnosis of dementia
[2] and to be one of the best discriminating factors
between healthy subjects and those who will later
develop Alzheimer disease [3]. In the clinical phase
of the disease, monitoring the changes in the lev-
els of memory dysfunctions may also provide impor-
tant clues as to the progress rate of dementia and
is taken into account when defining consecutive
stages of the disease process [4, 5]. 
Assessment of memory functions was sug-
gested not only to be indicative of the level of
general intellectual impairment but also to be
useful in diagnosing the type of dementia [6, 7].
The rationale for use of memory tests in differ-
entiating dementias of various types lies in the
fact that various memory functions involve
anatomically diverse cerebral structures or sys-
tems which in turn are differentially affected by
neuropathological processes leading to demen-
tias. For instance, impairments of memory infor-
mation storage were linked to lesions of the lim-
bic system and particularly the hippocampus,
retrieval dysfunctions were associated with dam-
age to the frontal-subcortical circuits, and short-
term memory failures were attributed to temporo-
parietal lesions [8]. 
A thorough assessment of different memory dys-
functions requires application of a battery of tasks
which are able to reliably measure isolated memo-
ry processes. Preferably, information learning, stor-
age and retrieval should be assessed separately as
they were shown to be differentially affected in mild
cognitive impairment, Alzheimer disease, vascular
dementia, dementia with Lewy bodies and fron-
totemporal dementia [9-12]. Also, both auditory and
visual stimuli should be covered to address various
information input modalities. Some authors even
suggested the discriminative value of olfactory stim-
uli [13]. Finally, the conditions for various informa-
tion retrieval methods should be utilized such as
immediate vs. delayed retrieval, free recall vs. cued
recall, or recall vs. recognition [14, 15].
There is a range of well-standardized memory
tests, such as the Benton Visual Retention Test
(BVRT), Rey Verbal Learning Test (RVLT), and Digit
Span, which are commonly used for various 
diagnostic purposes in patients with suspected or
actual dementia and which usually measure a sin-
gle, selected aspect of memory. The most popular
memory test batteries, which combine tasks
addressing separately various memory functions
and involving procedures for various information
retrieval methods, include the Wechsler Memory
Scale-3rd Edition, and the Free and Cued Selective
Reminding Test. Their application in the context of
the diagnosis of intellectual decline is common and
recommended [16]. 
However, the use of these test batteries in Poland
is impossible, since, so far, no Polish adaptations are
available. When carrying out neuropsychological
assessments in patients with suspected intellectu-
al deterioration, Polish psychologists either resort
to tests measuring single memory processes (BVRT,
RVLT) or apply a battery of experimental memory
tasks which most commonly lack normalization and
appropriate standardization, and therefore do not
fully meet the psychometric requirements expect-
ed for this type of diagnostic instruments [17].
Choynowski’s Memory Scale is a test battery
consisting of various memory tasks developed by
Mieczysław Choynowski in Poland in 1959. Due to
the fact that no normalization has ever been done,
the scale has almost been forgotten and is uncom-
mon in memory assessment in clinical settings.
However, a closer examination of this test battery
reveals that it has certain properties which can
make it a very useful instrument in dementia-relat-
ed assessment. First, it contains tasks that address
both auditory and visual stimuli, thus enabling an
evaluation of different memory modalities. Second,
these tasks involve various memory processes and
information retrieval methods, including immedi-
ate and delayed recall, free and cued recall, short-
term memory (digit span) and learning speed. 
Finally, the battery already possesses carefully
developed, unified instructions for administration
and scoring procedures, which provides a basis for
standardized psychometric measurement [18]. 
Appreciating the advantages of Choynowski’s
Memory Scale, we have already undertaken
research with the purpose of developing up-to-date
norms for this test. As part of this research we car-
ried out a study to examine whether this scale may
prove sensitive in memory assessment in the con-
text of dementia diagnosis. Therefore, the objec-
tives of this study were to evaluate the potential
utility of Choynowski’s Memory Scale to discrimi-
nate dementia patients from healthy controls and
to assess the associations between Choynowski’s
Memory Scale and the degree of the global intel-
lectual decline in dementia.
Material and methods
Participants
Thirty-two patients with a previously established
diagnosis of dementia, or with suspected demen-
tia in whom the diagnosis was later confirmed, took
part in the study. The patients were recruited into
the study when they presented to a doctor for med-
ical advice in the Department of Neurodegenera-
tive Diseases, Institute of Agricultural Medicine. The
group consisted of 17 patients with the diagnosis
of Alzheimer’s disease (AD) and 15 patients with
vascular dementia (VaD). The diagnoses were con-
sistent with the Diagnostic and Statistical Manual
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of Mental Disorders, 4th edition (DSM-IV) criteria
and National Institute of Neurological and Com-
municative Disorders and Stroke-AD and Related
Disorders Association (NINCDS-ADRDA) criteria for
possible or probable AD. The Modified Hachinski
Ischemic Score [19] was determined; all the patients
with vascular dementia had a composite score of
5 or more and imaging study consistent with vas-
cular dementia. Computed tomography (CT) or
magnetic resonance imaging (MRI) scans were
obtained routinely for all patients.
Patients included in the study had to be other-
wise healthy and ambulatory or ambulatory aided
(i.e., walker or cane), with vision and hearing suffi-
cient for compliance with the testing procedures.
Laboratory test values had to be within normal lim-
its or considered to be clinically insignificant by the
physician. All patients had to have a reliable care-
giver. Patients were excluded if they had evidence
of clinically significant and unstable, active gas-
trointestinal, renal, hepatic, endocrine, or systemic
disease, primary psychiatric diseases (notably DSM-
IV-defined depression), newly treated hypothy-
roidism, or a known or suspected history (within
the past 10 years) of alcoholism or drug abuse.
Additional reasons for exclusion included evidence
of neoplasm, insulin-dependent diabetes or dia-
betes not stabilized by diet or oral hypoglycaemic
agents, obstructive pulmonary disease or asthma,
recent (< 2 years) haematological/oncological dis-
orders, pernicious anaemia, or vitamin B12 or folate
deficiency as evidenced by blood concentrations
below the lower normal limit. 
The control group comprised 64 healthy subjects
whose scores were taken from the already existing
pool of normative data obtained from approxi-
mately 700 subjects. The controls were among the
persons who had been recruited into the study on
the normalization of Choynowski’s Memory Scale,
and the exclusion criteria were as follows: a known
central nervous system disease (dementia, epilep-
sy, Parkinson’s disease, or other), a history of cere-
brovascular disorders (including strokes), traumat-
ic brain injury, and severe psychiatric disorders
(schizophrenia, severe depression). For each patient
with dementia, two random controls were select-
ed out of those who matched the patient by age
and gender. We failed to find four control subjects
who matched the patients by exact age, so the con-
trols whose age was closest (within the range of
two years) to the patient were selected. 
The study was carried out in accordance with
the Institute of Agricultural Medicine Bioethical
Commission agreement. After complete description
of the study protocol, written informed consent was
obtained from the patients (if possible), the care-
givers, or the patient's representative (if applicable)
before beginning detailed screening activities. 
Psychological testing
Choynowski’s Memory Scale is a memory test
battery consisting of tasks addressing various
aspects of memory:
1) Auditory Memory – with immediate free recall of
20 pieces of information from a short story; the
raw scores range from 0 to 20;
2) Digit Span – examines short-term memory and
attention; the scores range from 0 to 14;
3) Picture Memory – visual stimuli (12 pictures of
common objects) are presented for 24 s with sub-
sequent free recall; the scores range from 0 to 12;
4) Learning Speed – measures the number of trials
necessary to memorize a sentence read aloud by
the examiner. The raw score is then reversed, so
that the higher score indicates better perform-
ance and the lower score worse performance;
the scores range from 1 to 11;
5) Digit Span Reversed – measures short-term
memory and intellectual flexibility activated by
the repetition of digit series in a reversed order;
the scores range from 0 to 12;
6) Visual Retention – examines the precision of
retention of visually presented geometric figures
which are drawn by the subject following the
exposure; the scores range from 0 to 14;
7) Associate Pairs – examines the recall of a list of
words associated with other cue words (cued
recall); the scores range from 0 to 21;
8) Delayed Recall – examines the delayed recall of
the 20 pieces of information provided in the first
task of the battery (Auditory Memory); the scores
range from 0 to 20.
The raw scores obtained in each task are
summed up to yield the total score – a global meas-
ure of memory processes. The theoretical range for
the total score is from 1 to 124 [18].
Mini Mental State Examination (MMSE) – is the
most commonly used measure of the global men-
tal status used in screening for dementia [20]. The
scale examines the following functions:
1) orientation to time and place;
2) memorization of 3 words;
3) attention (subtraction of 7s from 100);
4) recall of previously memorized words;
5) language functions (naming, repetition, com-
mand comprehension, reading, writing);
6) visual-spatial abilities (praxis – copying a picture
of two overlapping pentagons).
The advantages of this instrument include the
short time needed for its administration, yielding
a quantitative result, uncomplicated administration
procedure and good tolerability on the part of
patients [21]. Correct performance in all the tasks
is scored 30 points. The most commonly accepted
cut-off threshold for dementia is 23 points; how-
ever, the scores of MMSE were demonstrated to be
dependent on age and education level, and the
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norms have been proposed adjusted for these vari-
ables [22]. 
The Clock Drawing Test (CDT) is a simple, non-
verbal screening test used in diagnosis of demen-
tia. There are several variants of this test differing
in particulars concerning the reproduction method
(copying a pre-drawn clock vs. free drawing), time
which the subject is instructed to indicate (3:00
vs. 08:20 vs. 11:10) and scoring system (qualitative
vs. quantitative) [23]. In our study, we followed the
administration procedure suggested by Shah [24]
and the scoring system developed by Manos [25]
as they combine simplicity with a possibility of
quantitative scoring and of obtaining further qual-
itative information relevant for clinical diagnosis. 
In accordance with Shah’s [24] recommenda-
tions, each patient was first given a sheet of paper
with a pre-drawn circle signifying the clock face and
asked to complete it with appropriate numbers and
clock hands indicating 11:10 (the free drawing ver-
sion). Then, the patient was given a complete, pre-
drawn picture of the clock and instructed to copy
it (the copying version). The free drawing version is
assumed to examine language functions (verbal
comprehension of the command), memory func-
tions (recalling visual engrams stored in long-term
memory and recalling the instruction on the time
at which the clock hands were to be set – stored in
short-term memory), and executive functions (plan-
ning, sequencing, organizing), which generally cor-
respond to the temporal and frontal lobe activities.
The copying version is less dependent on language
and memory function, as it activates mainly per-
ceptual and visual-spatial abilities associated with
parietal lobe control.
The scoring system involved evaluation of the
spatial correctness of the numbers written on the
clock face and appropriateness of the clock hands
showing the indicated time. One point was given
for any of numbers 1, 2, 4, 5, 7, 8, 10 and 11 if they
were placed in their correct octant of the clock
face. One point was also given for the short hand
indicating number 11, and for the long hand indi-
cating number 2. The possible score range is from
0 to 10, with higher scores indicating better per-
formance. Scores lower than 8 indicate an
increased likelihood of intellectual impairment and
scores lower than 5 evidence severe intellectual
impairment [25]. 
Statistical analysis
Results are presented as means (M) ± standard
deviations (SD). The differences between the
patients and controls were tested by means of Stu-
dent t tests for independent groups. The associa-
tions between the scores on Choynowski’s Memo-
ry Scale and the scores on MMSE and CDT were
calculated as Pearson’s r correlation coefficients.
The test of significance of the differences between
correlation coefficients was also used. The results
of statistical tests were considered significant at
the level of p < 0.05.
Results
Participants’ characteristics
The match between the patients and controls
was very good – no statistically significant differ-
ences were found between these groups in sex, age
or residence (Table I). 
The mean score obtained for the patients on
MMSE was 19.42 although the variance in the
scores was considerable, reflecting various degrees
of intellectual decline ranging from severe to sub-
tle. The mean scores in both the copying and free
drawing versions of CDT were markedly lowered
and within the diagnostic range for intellectual
impairment. The mean performance in the copying
version was better than in the free drawing version,
and the difference was statistically significant 
(t = –3.67, p = 0.001). For healthy controls, the mean
score in MMSE was 29.03 and the range from 24 
to 30, indicating no impairment in cognitive func-
tioning. Similarly, healthy controls’ scores in both
free drawing and copying versions of CDT fell with-
Characteristics Patients with dementia Healthy controls Test statistic Value of p
Age 
Range (min-max) 36-84 36-84 – –
Mean (± SD) 69.78 (±10.86) 69.59 (±10.18) t = 0.83 0.93
Sex, n (%)
Men 10 (31.2%) 20 (31.2%) χ2 = 0.00 1.00
Women 22 (68.8%) 44 (68.8%)
Residence, n (%)
Urban  26 (81.3%) 39 (60.9%) χ2 = 4.59 0.10
Rural 6 (18.7%) 25 (39.1%)
Table I. The sociodemographic characteristics of patients and control groups134 Arch Med Sci 1, February / 2012
in the normative range, with means of 9.66 and
9.92, respectively (Table II).
Performance on Choynowski’s Memory Scale
All subscales of Choynowski’s Memory Scale
were found to discriminate patients with demen-
tia and healthy controls, with very significantly high-
er scores observed in the control group. The differ-
ences between the two groups were most
prominent for the total score. Detailed results
obtained for both groups are presented in Table III,
and Figures 1 and 2.
Choynowski’s Memory Scale and Performance
on MMSE and CDT in patients with dementia
Almost all subtests of Choynowski’s Memory
Scale showed very significant correlations with the
MMSE global score, with the strongest association
noted for the total score. Digit Span was the only
subtest of Choynowski’s Memory Scale unrelated to
global mental status and to most of its components
as measured by individual MMSE tasks. No signifi-
cant associations were observed between any of the
tasks in Choynowski’s Memory Scale and the men-
tal status component of Memorization. It is of note
that individual subtests of Choynowski’s Memory
Scale showed diverse correlational patterns with
components of mental status examination (Table IV).
The total score on Choynowski’s Memory Scale
was significantly positively correlated with both the
free drawing and copying versions of CDT. Again,
Digit Span was the only memory subtest unrelat-
ed to either of the CDT versions. In contrast, Digit
Span Reversed showed the highest correlations
with both variants of CDT. When the correlation
coefficients for particular memory tasks and the
free drawing or copying versions of CDT were com-
pared, no statistically significant differences were
found (Table V). This suggests no significant dif-
ferences in the strength of the associations
between the scores on Choynowski’s Memory Scale
and the two versions of CDT. 
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Variables Patients with dementia Healthy controls
Range Mean (± SD) Range Mean (± SD)
MMSE 
Orientation 0-10 6.28 (±3.18) 8-10 9.94 (±0.30)
Memorization 0-3 2.53 (±0.92) 3-3 3.00 (±0.00)
Attention 0-5 1.78 (±1.81) 2-5 4.56 (±0.89)
Recall 0-3 1.44 (±1.22) 1-3 2.72 (±0.58)
Language 0-8 6.53 (±1.93) 7-8 7.89 (±0.31)
Praxis 0-1 0.41 (±0.50) 0-1 0.92 (±0.27)
Total 3-30 19.42 (±6.41) 24-30 29.03 (±1.48)
CDT 
Free drawing  0-10 3.63 (±3.89) 7-10 9.66 (±0.82)
Copying 0-10 5.89 (±3.41) 9-10 9.92 (±0.27)
Table II. The clinical characteristics of the patients and control groups as measured by MMSE and CDT. The differ-
ences between the means for patients and controls were highly statistically significant for all the indices
Choynowski’s Memory Scale Patients with dementia Healthy controls Student’s t test 
Mean (± SD) Mean (± SD) tp
Auditory Memory 3.21 (±3.69) 7.71 (±4.23) –4.87 0.00
Digit Span 2.18 (±1.12) 3.50 (±1.57) –4.57 0.00
Pictures Memory 3.96 (±2.50) 6.67 (±1.83) –5.81 0.00
Learning Speed 1.57 (±1.29) 3.19 (±2.81) –3.79 0.00
Digit Span Reversed 1.57 (±1.37) 2.73 (±1.29) –3.91 0.00
Visual Retention 2.89 (±2.78) 7.09 (±4.08) –5.74 0.00
Associate Pairs 6.79 (±5.56) 11.09 (±3.93) –3.72 0.00
Delayed Recall 3.57 (±4.17) 7.56 (±4.22) –4.19 0.00
Total 25.39 (±18.37) 48.84 (±16.40) –6.07 0.00
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Discussion
In our study we aimed to evaluate the utility of
Choynowski’s Memory Scale in assessment of
patients with dementia. When performances on the
subtests of this scale were compared between
patients with dementia and healthy controls, very
significant differences were found between the
groups in all tasks. The differences between demen-
tia patients and healthy individuals on various
memory scales have been reported by numerous
authors and reflect memory disruption which usu-
ally occurs as one of the first symptoms in most
dementia syndromes [26]. Therefore, a valid mem-
ory task battery that is intended to be used in clin-
ical settings for the purposes of dementia diagno-
sis should show a high potential to discriminate
between dementia patients and healthy subjects.
Choynowski’s MMSE
Memory Scale
Orientation Memorization Attention Recall Language Praxis Total
Auditory Memory 0.68*** 0.06 0.46* 0.38* 0.24 0.07 0.66***
Digit Span 0.31 0.17 0.09 –0.05 0.20 –0.06 0.25
Pictures Memory 0.53** 0.15 0.36 0.56** 0.23 0.22 0.62***
Learning Speed 0.46* 0.20 0.55** 0.36 0.13 0.33 0.59***
Digit Span Reversed 0.51** –0.02 0.71*** 0.22 0.47* 0.26 0.68***
Visual Retention 0.51** 0.02 0.63*** 0.23 0.37 0.43* 0.65***
Associate Pairs 0.68*** 0.04 0.63*** 0.56** 0.35 0.27 0.79***
Delayed recall 0.65*** 0.08 0.49** 0.55** 0.16 0.17 0.68***
Total 0.72*** 0.17 0.60*** 0.50** 0.33 0.29 0.81***
Table IV. Pearson’s r correlation coefficients between the scores on Choynowski’s Memory Scale and MMSE in patients
with dementia
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Figure 1. The mean (+ SD) raw scores on Choynowski’s Memory Scale tasks in patients with dementia and in healthy
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Figure 2. The mean (+ SD) total scores on Choynows-
ki’s Memory Scale in patients with dementia and
healthy controls
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Our findings provide support for high sensitivity of
Choynowski’s Memory Scale in differentiating
patients with dementia from non-demented sub-
jects. 
Additionally, the scores on almost all tasks of
Choynowski’s Memory Scale were significantly
associated with the degree of global intellectual
decline as measured by MMSE. This finding sug-
gests that Choynowski’s Memory Scale can be used
not only for the purpose of discriminating healthy
subjects and dementia patients but can also be uti-
lized in patients already diagnosed with dementia
to monitor the progress of the disease or potential
effectiveness of applied therapies [5, 27, 28]. 
The only task of Choynowski’s Memory Scale
which was found to be unrelated to the global men-
tal status as measured by MMSE was Digit Span.
A similar finding, however, was also reported in oth-
er studies, showing that this task is not sensitive
to dementia [29]. It follows from our results that it
is Digit Span Reversed rather than Digit Span alone
that is much more sensitive to dementia-related
intellectual decline. The lack of significant correla-
tions between Choynowski’s Memory Scale and the
mental state component of Memorization probably
followed from low variance in the latter task. The
repetition of the three words in MMSE is usually
unaffected up to severe stages of dementia, which
leads to a greatly reduced variance of scores. How-
ever, it is also possible that the memory tasks
included in Choynowski’s Memory Scale are not
actually related to performance in this subcompo-
nent of the mental status. 
Most of the tasks of Choynowski’s battery were
also shown in our study to correlate with perform-
ance on CDT, and these findings attest to the fact
that actual memory disruption, as captured by
Choynowski’s scale, is significantly related to exec-
utive dysfunctions, as measured by CDT. This may
add to the evidence on validity of Choynowski’s
scale. No statistically significant differences
between the correlations for the free drawing or
copying version of CDT and Choynowski’s scale
were observed in our study. This suggests that even
though the scores on Choynowski’s memory tasks
are related to executive functions, they may not dis-
criminate between more subtle differences in exec-
utive dysfunctions, as captured by the free draw-
ing and copying versions of CDT. This finding seems
noteworthy for the interpretation of Choynowski’s
scale scores in the context of cognitive impairment
diagnosis, as data from the literature indicate that
patients with most types of dementia usually reveal
worse performance in the free drawing version than
in the copying version of CDT [30], and this dis-
tinction may not be reflected in the scores of
Choynowski’s Memory Scale.
Three of the memory tasks, i.e. Digit Span
Reversed, Visual Retention and Associate Pairs,
showed highly significant correlations with both
CDT versions, and the total score in Choynowski’s
Memory Scale revealed strong correlations with
both the free drawing and copying versions of CDT.
This confirms the sensitivity of Choynowski’s bat-
tery to various degrees of intellectual decline in
dementia, as measured by CDT. As CDT and MMSE
address slightly different aspects of the mental sta-
tus, with MMSE emphasizing orientation and ver-
bal functions and CDT putting stress on visual-spa-
tial abilities [17], the differences in the correlation
pattern between memory tasks and these two
measures of global intellectual impairment are nat-
ural and could be expected.
In conclusion,  this study was, to our knowledge,
the first attempt to validate Choynowski’s Memo-
ry Scale in patients with dementia. We demon-
strated that all tasks from this battery showed high-
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Choynowski’s Memory Scale CDT Significance of the difference 
between the correlation coefficients
Free drawing Copying p
Auditory Memory 0.52* 0.55** 0.44
Digit Span –0.07 0.18 0.17
Pictures Memory 0.36 0.44* 0.36
Learning Speed 0.57** 0.38 0.17
Digit Span Reversed 0.78*** 0.72*** 0.30
Visual Retention 0.72*** 0.55** 0.14
Associate Pairs 0.67*** 0.62*** 0.37
Delayed Recall 0.53* 0.44* 0.33
Total 0.66*** 0.61*** 0.38
Table V. Pearson’s r correlation coefficients between the scores on Choynowski’s Memory Scale and CDT in patients
with dementia
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ly significant differences between patients with
dementia and healthy controls, and that scores on
most of these tasks were significantly correlated
with the degree of intellectual decline in dementia.
Our findings provide support for the potential use-
fulness of this instrument in clinical settings, par-
ticularly in the situation when no standardized mul-
tidimensional memory battery is currently available
for clinical diagnosis in Poland. 
A limitation of our study is the small sample size
of patients with dementia and a deviation from the
perfect match between the patients and controls
with respect to age. Therefore, further research on
larger patient samples is needed, particularly in
order to calculate the precise sensitivity and speci-
ficity of Choynowski’s Memory Scale in detecting
dementia. Future studies are also required to inves-
tigate the potential usefulness of this tool in differ-
entiating patients with diverse types of dementia. 
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